FDA — authorised 2 May 1997
- Application: NDA018469
- Marketing authorisation holder: ALCON
- Indication: Manufacturing (CMC)
- Status: approved
FDA authorised Glutinal on 2 May 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 2 May 1997.
ALCON holds the US marketing authorisation.